Yusimox

Yusimox

amoxicillin

Manufacturer:

Ifars
Concise Prescribing Info
Contents
Amoxicillin trihydrate
Indications/Uses
Skin & soft tissue infections due to non-penicillinase-producing Staph, Streptococcus spp, E. coli. Resp tract infection due to H. influenzae, Streptococcus, S. pneumoniae, non-penicillinase-producing Staph, E. coli. GUT infection due to E. coli, P. mirabilis, S. faecalis. Gonorrhea due to N. gonorrheae.
Dosage/Direction for Use
Adult & childn >20 kg 250-500 mg 8 hrly. Childn <20 kg 20-40 mg/kg daily in divided doses 8 hrly. Patients under peritoneal dialysis Max dose: 500 mg daily. Gonococcal urethritis 3 g as a single dose.
Administration
May be taken with or without food: May be taken w/ meals for better absorption & to reduce GI discomfort.
Contraindications
Hypersensitivity to β-lactam antibiotics ie, penicillins, cephalosporins.
Special Precautions
Not for treatment of meningitis or bone & joint infections. Patients w/ lymphatic leukemia. May cause severe colitis. Perform kidney, liver function & blood test during prolonged therapy. Patients w/ kidney failure. Pregnancy, lactation.
Adverse Reactions
Erythematous maculopapular rashes, urticaria, skin rashes, serum sickness. Anaphylaxis reactions. GI disturbances eg, nausea, vomiting, diarrhea. Hematological reactions (reversible).
Drug Interactions
Probenecid may increase & prolong blood level of amoxicillin. Concomitant use w/ allopurinol may increase the incidence of skin reactions.
MIMS Class
Penicillins
ATC Classification
J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended spectrum. Used in the systemic treatment of infections.
Presentation/Packing
Form
Yusimox caplet 500 mg
Packing/Price
10 × 10's
Form
Yusimox dry syr 125 mg/5 mL
Packing/Price
(strawberry flavor) 60 mL x 1's
Form
Yusimox forte dry syr 250 mg/5 mL
Packing/Price
(strawberry flavor) 60 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in